Mylan NV (NASDAQ: MYL) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that the United States Food and Drug Administration has approved one of its treatments. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk … Read more
Mylan NV (NASDAQ: MYL) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company was the center of an analyst upgrade, leading to excitement among investors and sending the stock on a run for the top. Today, we’ll talk about the analyst upgrade, what we’re seeing from MYL, … Read more
Pulmatrix Inc (NASDAQ: PULM) | Mylan Br (NASDAQ: MYL) Pulmatrix was off to a rough day early on. That is, until minutes ago, when rumors broke of a potential takeover in the works. As a result of the rumor, investors got excited, pushing the stock up dramatically and prompting our partners at Trade Ideas to … Read more
Mylan Br (NASDAQ: MYL) | Abbott Laboratories (NYSE: ABT) Mylan is having a rough day in the market today, and for good reason. Early this morning, it was announced that Abbott Laboratories has made the decision to sell a large amount of shares, sending the stock tumbling. As a result of the declines, our partners … Read more
Mylan Br (NASDAQ: MYL) Mylan was off to what seemed like it was going to be a rough day in the market today. At the opening bell, the stock was trading slightly in the green. From there, it quickly turned red as it took a mad-dash for the bottom. However, minutes ago, things changed. The … Read more
Mylan Inc. (NASDAQ:MYL) On August 10th, the CEO of Mylan, Heather Bresch, assured that reliance on the Epipen was starting to ware down. This was the day the CEO was talking about earnings on the conference call. The CEO tried to downplay the whole necessity of the Epipen. Maybe it was to take attention away … Read more
Mylan Inc (NASDAQ: MYL) Mylan has had a rough time in the market as of late, and for good reason. The company’s product, Epipen has taken center stage among news outlets thanks to recent price hikes, and that’s concerning investors. As a result of the pressure, the company announced new programs that will likely cost … Read more
Perrigo (NYSE: PRGO) Perrigo is having an incredibly rough day in the market today, and for good reason. We’re seeing a bit of a surprise CEO shakeup at the company. Today, we’ll talk about the change to the CEO position at the company, how investors are reacting to the news, and what we can expect … Read more
Mylan Inc (NASDAQ: MYL) Mylan Inc reported its earnings yesterday as expected. However, the earnings weren’t the only big topic of the call. During the earnings call, the company made it clear that they’re still pushing for the acquisition of Perrigo Co. plc (PRGO). So today, we’ll talk about the earnings, the acquisition, and more! … Read more
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) Mylan Inc (NASDAQ: MYL) Teva Pharmaceutical Industries is a multinational pharmaceutical giant that focuses on generic and specialized treatments; and they’ve made a big play today. The company wants to acquire Mylan Inc, and is willing to pay a premium for it! Why TEVA Wants To Acquire MYL … Read more